Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

XR 9051 MeSH Supplementary Concept Data 2025


MeSH Supplementary
XR 9051
Unique ID
C118656
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C118656
Entry Term(s)
(N-(4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl)ethyl)phenyl)-3-((3Z,6Z)-6-benzylidene-1-methyl-2,5-dioxo-3-pipera zinylidene)methylbenzamide)
XR9051
Registry Numbers
0
Previous Indexing
*ISOQUINOLINES (1999-2003)
Heading Mapped to
*Benzylidene Compounds
*Tetrahydroisoquinolines
Frequency
3
Note
a potent modulator of P-glycoprotein mediated multidrug resistance
Source
Br J Cancer 1999 Apr;79(11-12):1672-8
Date of Entry
1999/05/04
Revision Date
2003/08/08
XR 9051 Preferred
(N-(4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl)ethyl)phenyl)-3-((3Z,6Z)-6-benzylidene-1-methyl-2,5-dioxo-3-pipera zinylidene)methylbenzamide) Broader
page delivered in 0.005s